| Authors: |
Hu YC; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA., Kusters CDJ; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA; Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA; Jane and Terry Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA., Paul KC; Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA., Folle AD; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA., Zhang K; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA., Shih IF; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA., Keener AM; Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; Parkinson's Disease Research, Education, and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Bronstein JM; Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA., Ritz BR; Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA; Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; Department of Environmental Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA, USA. Electronic address: britz@ucla.edu. |
